Physician profile
David N Lam
NPI 1962598243
$18,776.25
in general payments reported to CMS, 2019-2025
27 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $216 · 2021: $10K · 2022: $1,519 · 2023: $5,099 · 2024: $435 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,207 · Travel and Lodging: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,207.24 |
| Travel and Lodging | $500.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,112.35 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Tela Bio, INC. | $463.45 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $152.01 | 2022-2024 | Phasix Mesh |
| Smith+Nephew, INC. | $129.44 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Gilead Sciences, INC. | $105.60 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.51 | 2022-2024 | Gattex |
| Ethicon US, LLC | $69.39 | 2019-2024 | Enseal X1 |
| Ets Wound Care LLC | $64.22 | 2025 | Mirragen Advanced Wound Matrix |
| Misonix INC | $61.52 | 2019 | |
| Acera Surgical, INC. | $41.21 | 2025 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $36.31 | 2024 | |
| Tei Biosciences INC | $35.39 | 2019 | |
| Endo Pharmaceuticals INC. | $33.01 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $30.31 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $26.29 | 2022 | |
| Neuros Medical, INC. | $24.77 | 2025 | Altius |
| Baxter Healthcare | $22.88 | 2023 | Tisseel |
| Organogenesis INC. | $22.49 | 2020 | |
| Abbott Laboratories | $19.46 | 2023 | Proclaim |
| Standard Bariatrics, INC. | $18.70 | 2022 | |
| Medtronic, INC. | $17.22 | 2022 | |
| Avanos Medical | $15.90 | 2025 | On-Q Pump and Accessories |
| Musculoskeletal Transplant Foundation INC. | $15.06 | 2019 | |
| Coopersurgical, INC. | $13.81 | 2024 | Lone Star Retraction System |
| Rti Surgical, INC | $13.43 | 2022 | |
| Kerecis Limited | $7.52 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.